Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endome | Genmab has shared the first data on ...

AbbVie's Elahere has been shown to reduce the risk of death in patients with folate receptor-alpha (FRα) positive, platinum-resistant ovarian cancer by a third, reinforcing its blockbuster ...

Specifically, Elahere (mirvetuximab soravtansine) can be used in adults with platinum-resistant, FRα-expressing high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer ...

Advanced ovarian cancer patients may also turn to a type of antibody-drug conjugate called Elahere (molecular name mirvetuximab soravtansine) that has been shown to help patients live longer without ...

I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact ...

Ovarcome ovarian cancer gala was held over the weekend in Houston. Survivors, known as Ovarcomers, and their doctors were in ...

Dr Moore stated: “PARP inhibitors are the first truly targeted therapy to benefit patients with ovarian cancer...transformative in a biomarker selected way” and noted: “Best place to use ...

Discussing ‘cure’ may risk oncologists’ credibility, should a patient’s ovarian cancer recur,” researchers wrote.

Ovarian cancer is a relatively manageable malignancy when diagnosed at an early stage, but late-stage detection almost always translates into a poor prognosis. Researchers have been vigorously ...

Is abdominal bloating a sign of ovarian cancer? In an interview with HT Lifestyle, Dr Renuka Gupta, senior consultant, gynae oncology, Fortis Hospital Shalimar Bagh said, “Abdominal bloating can ...

Persistent bloating and pelvic pain, often dismissed as normal menstrual symptoms, could indicate ovarian cancer, a condition known as the 'silent killer'. Early detection is crucial, as the ...

CK Wang, MD, chief medical officer of COTA, highlights how a lack of screening tools and declining ob-gyn pipeline can ...